• FATIMA S. ALARYANI Biology Department, Faculty of Sciences, Jeddah University, Jeddah, Saudi Arabia
  • SALMA SALEH TURKI ALRDAHE Department of Biology, Faculty of Science, University of Tabuk, Tabuk, Saudi Arabia




Colorectal cancer, Mortality, Surgery, Chemotherapy, Incidence, Screening


Colorectal cancer (CRC) is considered as the third most frequent cancer in the world and the incidence increases with increasing age. CRC accounts for nearly 9 % of all cancer incidence, with an estimated 1.4 million cases happening in 2012. The aim of this paper is to provide a review of incidence, risk factors, screening strategies, and treatment of colorectal cancer. We searched the studies in five English databases, including Web of Science, PubMed, Scopus, EMBASE, and Google Scholar with no limitation in publication time to find all papers regarding colorectal cancers. Papers with any language were included in the first step of search if they had an English abstract. We used the following words and terms including colorectal cancer, treatment, risk factor, diagnosis, chemotherapy, radiotherapy, surgery. Geographical variations and different time courses in the CRC incidence indicate that environmental factors and lifestyle are major factors in the development of this disease. The main preventable risk factors for CRC are nutrition, a high-fat diet, a low-fiber diet, obesity and physical inactivity, smoking and alcohol consumption, aspirin and nonsteroidal anti-inflammatory drugs, and some non-preventable risk factors such as age, gender, race, and diabetes mellitus. Colonoscopy remains the study of choice to diagnose colorectal cancer. Prior to any treatment, CT imaging of chest, abdomen and pelvis with contrast is needed for staging the patient’s CRC. The preferred option for localized colorectal cancer is surgery (etc, laparoscopic surgery, colostomy for rectal cancer); whereas the adjuvant chemotherapy is generally recommended for patients with lymph node metastases. Targeted treatment of colorectal cancer by monoclonal antibodies are important bioengineered proteins that can help the body's natural immune response to detect, attack, and kill cancer cells. Monoclonal antibodies may be used alone or in combination with other treatments such as chemotherapy. CRC accounts an important health problem worldwide that is estimated to increase because of the growth and aging of the population, and because of the adoption of at-risk manners and lifestyles, particularly in economically less developed countries. Screening has been confirmed to significantly decrease mortality and can prevent the onset of the disease. More international efforts are required to situate into practice targeted prevention approaches that might reduce the burden of CRC worldwide.


Download data is not yet available.


Higginson J, Muir CS, Munoz N. Human cancer: epidemiology and environmental causes. Cambridge University Press; 1992 Jun 4.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T. Cancer statistics. CA 2008;58(2):71-96.

Haraldsdottir S, Einarsdottir HM, Smaradottir A, Gunnlaugsson A, Halfdanarson TR. Colorectal cancer- review. Laeknabladid. 2014;100(2):75-82. doi: 10.17992/lbl.2014.02.531, PMID 24639430.

Rahimi Pordanjani S, Baeradeh N, Lotfi MH, Pourmohammadi B. Epidemiology of colorectal cancer: incidence, mortality, survival rates and risk factors. Razi J Med Sci. 2016;23(144):41-50.

Marley AR, Nan H. Epidemiology of colorectal cancer. Int J Mol Epidemiol Genet. 2016;7(3):105-14. PMID 27766137.

Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89-103. doi: 10.5114/ pg.2018.81072, PMID 31616522.

Favoriti P, Carbone G, Greco M, Pirozzi F, Pirozzi RE, Corcione F. Worldwide burden of colorectal cancer: a review. Updates Surg. 2016;68(1):7-11. doi: 10.1007/s13304-016-0359-y, PMID 27067591.

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90. doi: 10.3322/caac.20107, PMID 21296855.

Sandler RS. Epidemiology and risk factors for colorectal cancer. Gastroenterol Clin North Am. 1996 Dec 1;25(4):717-35. doi: 10.1016/s0889-8553(05)70271-5, PMID 8960889.

Hsing AW, McLaughlin JK, Chow WH, Schuman LM, Co Chien HT, Gridley G, Bjelke E, Wacholder S, Blot WJ. Risk factors for colorectal cancer in a prospective study among US white men. Int J Cancer. 1998 Aug 12;77(4):549-53. doi: 10.1002/(sici)1097-0215(19980812)77:4<549:aid-ijc13>3.0.co;2-1, PMID 9679757.

Crawford Williams F, March S, Ireland MJ, Rowe A, Goodwin B, Hyde MK, Chambers SK, Aitken JF, Dunn J. Geographical variations in the clinical management of colorectal cancer in Australia: a systematic review. Front Oncol. 2018;8:116. doi: 10.3389/fonc.2018.00116, PMID 29868464.

Ahmad A, Gunjan HS. Novel technologies for cancer treatment. Crit Rev. 2020;7(10):1107-11.

Biagi JJ, Raphael MJ, Mackillop WJ, Kong W, King WD, Booth CM. Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. JAMA. 2011;305(22):2335-42. doi: 10.1001/jama.2011.749, PMID 21642686.

Zlobec I, Lugli A. Prognostic and predictive factors in colorectal cancer. Postgrad Med J. 2008 Aug 1;84(994):403-11. doi: 10.1136/jcp.2007.054858, PMID 18832400.

Poornakala S, Prema NS. A study of morphological prognostic factors in colorectal cancer and survival analysis. Indian J Pathol Microbiol. 2019 Jan 1;62(1):36-42. doi: 10.4103/IJPM.IJPM_91_18, PMID 30706857.

Johnson CM, Wei C, Ensor JE, Smolenski DJ, Amos CI, Levin B, Berry DA. Meta-analyses of colorectal cancer risk factors. Cancer Causes Control. 2013;24(6):1207-22. doi: 10.1007/s10552-013-0201-5, PMID 23563998.

Ryan-Harshman M, Aldoori W. Diet and colorectal cancer: review of the evidence. Can Fam Physician. 2007;53(11):1913-20. PMID 18000268.

Wakai K, Hirose K, Matsuo K, Ito H, Kuriki K, Suzuki T, Kato T, Hirai T, Kanemitsu Y, Tajima K. Dietary risk factors for colon and rectal cancers: a comparative case-control study. J Epidemiol. 2006;16(3):125-35. doi: 10.2188/jea.16.125, PMID 16710081.

Navarro A, Muñoz SE, Lantieri MJ, del Pilar Diaz M, Cristaldo PE, de Fabro SP, Eynard AR. Meat cooking habits and risk of colorectal cancer in Cordoba, Argentina. Nutrition. 2004;20(10):873-7. doi: 10.1016/j.nut.2004.06.008, PMID 15474875.

Moshfeghi K, Mohammad Beigi A, Hamedi Sanani D, Bahrami M. Evaluation the role of nutritional and individual factors in colorectal cancer. ZJRMS 2010;13(4):12-7.

Keyghobadi N, Lotfi M, Fallahzadeh H, Akhondi M. Nutritional factors related to colorectal cancer in the residents of Yazd City, Iran. J Health Dev. 2013;2(3):171-81.

Martínez ME. Primary prevention of colorectal cancer: lifestyle, nutrition, exercise. Recent Results Cancer Res. 2005;166:177-211. doi: 10.1007/3-540-26980-0_13, PMID 15648191.

Ganesh B, Talole SD, Dikshit R. Tobacco, alcohol and tea drinking as risk factors for esophageal cancer: A case-control study from Mumbai, India. Cancer Epidemiol. 2009;33(6):431-4. doi: 10.1016/j.canep.2009.09.002. PMID 19846360.

Michels KB, Edward Giovannucci E, Joshipura KJ, Rosner BA, Stampfer MJ, Fuchs CS, Colditz GA, Speizer FE, Willett WC. Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers. J Natl Cancer Inst. 2000;92(21). doi: 10.1093/jnci/92.21.1740, PMID 11058617.

Doyle VC. Nutrition and colorectal cancer risk: a literature review. Gastroenterol Nurs. 2007;30(3):178-82. doi: 10.1097/01.SGA.0000278165.05435.c0, PMID 17568255.

Steinmetz KA, Kushi LH, Bostick RM, Folsom AR, Potter JD. Vegetables, fruit, and colon cancer in the lowa women’s health study. Am J Epidemiol. 1994;139(1):1-15. doi: 10.1093/oxfordjournals.aje.a116921.

Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg. 2009;22(4):191-7. doi: 10.1055/s-0029-1242458, PMID 21037809.

Moghaddam AA, Woodward M, Huxley R. Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev. 2007;16(12):2533-47. doi: 10.1158/1055-9965.EPI-07-0708, PMID 18086756.

Zisman AL, Nickolov A, Brand RE, Gorchow A, Roy HK. Associations between the age at diagnosis and location of colorectal cancer and the use of alcohol and tobacco: implications for screening. Arch Intern Med. 2006;166(6):629-34. doi: 10.1001/archinte.166.6.629, PMID 16567601.

Klatsky AL, Armstrong MA, Friedman GD, Hiatt RA. The relations of alcoholic beverage use to colon and rectal cancer. Am J Epidemiol. 1988;128(5):1007-15. doi: 10.1093/oxfordjournals.aje.a115045, PMID 3189277.

Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, Petrelli N, Pipas JM, Karp DD, Loprinzi CL, Steinbach G, Schilsky R. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med. 2003;348(10):883-90. doi: 10.1056/NEJMoa021633, PMID 12621132.

Lee YC, Hsu CY, Chen SL, Yen AM, Chiu SY, Fann JC, Chuang SL, Hsu WF, Chiang TH, Chiu HM, Wu MS, Chen HH. Effects of screening and universal healthcare on long-term colorectal cancer mortality. Int J Epidemiol. 2019;48(2):538-48. doi: 10.1093/ije/dyy182, PMID 30184208.

Roy HK, Bianchi LK. Differences in colon adenomas and carcinomas among women and men: potential clinical implications. JAMA. 2009;302(15):1696-7. doi: 10.1001/jama.2009.1499, PMID 19843905.

Murphy G, Devesa SS, Cross AJ, Inskip PD, McGlynn KA, Cook MB. Sex disparities in colorectal cancer incidence by anatomic subsite, race and age. Int J Cancer. 2011;128(7):1668-75. doi: 10.1002/ijc.25481, PMID 20503269.

Wong RJ. Marked variations in proximal colon cancer survival by race/ethnicity within the United States. J Clin Gastroenterol. 2010;44(9):625-30. doi: 10.1097/MCG.0b013e3181c64a7a, PMID 19996985.

Ma J, Giovannucci E, Pollak M, Leavitt A, Tao Y, Gaziano JM, Stampfer MJ. A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst. 2004;96(7):546-53. doi: 10.1093/jnci/djh082, PMID 15069117.

Flood A, Strayer L, Schairer C, Schatzkin A. Diabetes and risk of incident colorectal cancer in a prospective cohort of women. Cancer Causes Control. 2010;21(8):1277-84. doi: 10.1007/s10552-010-9555-0, PMID 20383575.

Vinikoor LC, Long MD, Keku TO, Martin CF, Galanko JA, Sandler RS. The association between diabetes, insulin use, and colorectal cancer among Whites and African Americans. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1239-42. doi: 10.1158/1055-9965.EPI-08-1031, PMID 19336553.

Fitzpatrick Lewis D, Ali MU, Warren R, Kenny M, Sherifali D, Raina P. Screening for colorectal cancer: a systematic review and meta-analysis. Clin Colorectal Cancer. 2016;15(4):298-313. doi: 10.1016/j.clcc.2016.03.003, PMID 27133893.

Whitlock EP, Lin J, Liles E, Beil T, Fu R, O’Connor E, Thompson RN, Cardenas T. Screening for colorectal cancer: an updated systematic review. Annals of Oncology. 2013;24(8):1963-72.

Lea D, Haland S, Hagland HR, Soreide K. Accuracy of TNM staging in colorectal cancer: a review of current culprits, the modern role of morphology and stepping-stones for improvements in the molecular era. Scand J Gastroenterol. 2014;49(10):1153-63. doi: 10.3109/00365521.2014.950692, PMID 25144865.

Resch A, Langner C. Lymph node staging in colorectal cancer: old controversies and recent advances. World J Gastroenterol. 2013;19(46):8515-26. doi: 10.3748/wjg.v19.i46.8515, PMID 24379568.

Macrae FA, Bendell J, Tanabe KK, Savarese D, Grover S. Clinical presentation, diagnosis, and staging of colorectal cancer. Up to Date 2017.

Nagtegaal ID, Quirke P, Schmoll HJ. Has the new TNM classification for colorectal cancer improved care? Nat Rev Clin Oncol. 2011;9(2):119-23. doi: 10.1038/nrclinonc.2011.157, PMID 22009076.

Moreno CC, Mittal PK, Sullivan PS, Rutherford R, Staley CA, Cardona K, Hawk NN, Dixon WT, Kitajima HD, Kang J, Small WC, Oshinski J, Votaw JR. Colorectal cancer initial diagnosis: screening colonoscopy, diagnostic colonoscopy, or emergent surgery, and tumor stage and size at initial presentation. Clin Colorectal Cancer. 2016;15(1):67-73. doi: 10.1016/ j.clcc.2015.07.004, PMID 26602596.

Hall C, Clarke L, Pal A, Buchwald P, Eglinton T, Wakeman C, Frizelle F. A review of the role of carcinoembryonic antigen in clinical practice. Ann Coloproctol. 2019;35(6):294-305. doi: 10.3393/ac.2019.11.13, PMID 31937069.

Mao Y, Chen B, Wang H, Zhang Y, Yi X, Liao W, Zhao L. Diagnostic performance of magnetic resonance imaging for colorectal liver metastasis: A systematic review and meta-analysis. Sci Rep. 2020;10(1):1969. doi: 10.1038/s41598-020-58855-1, PMID 32029809.

Golfinopoulos V, Pentheroudakis G, Pavlidis N. Treatment of colorectal cancer in the elderly: a review of the literature. Cancer Treat Rev. 2006;32(1):1-8. doi: 10.1016/ j.ctrv.2005.10.002, PMID 16337087.

Simmonds P, Best L, George S, Baughan C, Buchanan R, Davis C, Fentiman I, Gosney M, Northover J, Williams C. Surgery for colorectal cancer in elderly patients: a systematic review. Lancet. 2000;356(9234):968-74. doi: 10.1016/S0140-6736(00)02713-6.

Reza MM, Blasco JA, Andradas E, Cantero R, Mayol J. Systematic review of laparoscopic versus open surgery for colorectal cancer. Br J Surg. 2006;93(8):921-8. doi: 10.1002/bjs.5430, PMID 16845692.

Vonk Klaassen SM, de Vocht HM, den Ouden ME, Eddes EH, Schuurmans MJ. Ostomy-related problems and their impact on quality of life of colorectal cancer ostomates: a systematic review. Qual Life Res. 2016;25(1):125-33. doi: 10.1007/s11136-015-1050-3, PMID 26123983.

Minami Y, Kudo M. Radiofrequency ablation of liver metastases from colorectal cancer: a literature review. Gut Liver. 2013;7(1):1-6. doi: 10.5009/gnl.2013.7.1.1, PMID 23422905.

Zhao JK, Chen NZ, Zheng JB, He S, Sun XJ. Laparoscopic versus open surgery for rectal cancer: results of a systematic review and meta-analysis on clinical efficacy. Mol Clin Oncol. 2014;2(6):1097-102. doi: 10.3892/mco.2014.345, PMID 25279204.

Ciardiello D, Vitiello PP, Cardone C, Martini G, Troiani T, Martinelli E, Ciardiello F. Immunotherapy of colorectal cancer: challenges for therapeutic efficacy. Cancer Treat Rev. 2019;76:22-32. doi: 10.1016/j.ctrv.2019.04.003, PMID 31079031.

Basini J, Rayadurgam S, Dakshinamurthy S. An overview of colorectal cancer: implication of two medicinal plants in their treatment. Asian J Pharm Clin Res. 2019;12(7):47-52.

Aithal RR, Shetty RS, S BV, Mallya SD, Shenoy KR, Nair S. Colorectal cancer and its risk factors among patients attending a tertiary care hospital in Southern Karnataka, India. Asian J Pharm Clin Res. 2017;10(4):109-12.

Mak G, Moschetta M, Arkenau HT. Immunotherapy in colorectal cancer. Colorectal cancer: from pathogenesis to treatment; 2016. p. 301.

Gustavsson B, Carlsson G, Machover D, Petrelli N, Roth A, Schmoll HJ, Tveit KM, Gibson F. A review of the evolution of systemic chemotherapy in the management of colorectal cancer. Clin Colorectal Cancer. 2015;14(1):1-10. doi: 10.1016/j.clcc.2014.11.002, PMID 25579803.

Jalil O, Claydon L, Arulampalam T. Review of neoadjuvant chemotherapy alone in locally advanced rectal cancer. J Gastrointest Cancer. 2015;46(3):219-36. doi: 10.1007/s12029-015-9739-7, PMID 26133151.

Poulsen LØ, Qvortrup C, Pfeiffer P, Yilmaz M, Falkmer U, Sorbye H. Review on adjuvant chemotherapy for rectal cancer- why do treatment guidelines differ so much? Acta Oncol. 2015;54(4):437-46. doi: 10.3109/0284186X.2014.993768, PMID 25597332.

Tam SY, Wu VWC. A review on the special radiotherapy techniques of colorectal cancer. Frontiers in Oncology. 2019;9:208. doi: 10.3389/fonc.2019.00208, PMID 31001474.

Xie YH, Chen YX, Fang JY. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduction and Targeted Therapy. 2020;5(1):1-30:22. doi: 10.1038/s41392-020-0116-z, PMID 32296018.



How to Cite

ALARYANI, F. S., & TURKI ALRDAHE, S. S. (2022). A REVIEW OF TREATMENT, RISK FACTORS, AND INCIDENCE OF COLORECTAL CANCER. International Journal of Applied Pharmaceutics, 14(1), 1–6. https://doi.org/10.22159/ijap.2022v14i1.42820



Review Article(s)